Вы находитесь на странице: 1из 37

Internship Report on

"Service Performance of IBN SINA"

Internship Report On Service Performance of IBN SINA

SUPERVISED BY: Nighat Farzana Lecturer School of Business Administration Uttara University, Bangladesh

SUBMITTED BY: Mazharul Islam ID: M20911111090 18th batch Major in Marketing

Department of Business Administration Uttara University, Dhaka

Date: 31st December, 2012

1|Page

Internship Report on

"Service Performance of IBN SINA"

Internship Report On Service Performance of IBN SINA

SUPERVISED BY: Nighat Farzana Lecturer School of Business Administration Uttara University, Bangladesh

SUBMITTED BY: Mazharul Islam ID: M20911111090 18th batch Major in Marketing

Department of Business Administration Uttara University, Dhaka

Date: 31st December, 2012

2|Page

Internship Report on

"Service Performance of IBN SINA"

Letter of Transmittal
Date: 31st December, 2012 Nighat Farzana School of Business Administration Uttara University, Dhaka. Subject: Transmitting the internship report on Service Performance of IBN SINA.

Dear Madam, It is my pleasure to submit this internship report on the topic Service Performance of IBN SINA. I have tried my best to analyze all necessary information related to my topic and present as affectionately as possible. It is not impossible that there will be minor mistakes in this report. But still I hope that this report will provide the appropriate analysis on the topic of Service Performance of IBN SINA. In conclusion, I want to express my thanks to you, as without your co-operation it would barely impossible for me to prepare this report related to my subject. If you need any help to interpret anything of this report, please let me inform. Thanking you Mazharul Islam ID: M20911111090 Major: Marketing School of Business Administration Program B.B.A. Section 18th (B) 3|Page

Internship Report on

"Service Performance of IBN SINA"

Preface
After completion our BBA final examination, Internship Program is an important part for our post-graduation degree. For this reason, I perused my Internship Program in IBN SINA pharmaceuticals Ltd, from 14th October to 10th December 2012. The duration of the program was two months. Like other employees of IBN SINA pharmaceuticals Ltd, I worked there at regular basis aiming to acquire practical knowledge which will help me in my practical life. In two months, I tried with my best ability to learn about the instructions, characteristics, natures, functions, competitiveness, workflows etc. of pharmaceuticals sectors. IBN SINA pharmaceuticals Ltd is one of the leading pharmaceuticals in the country. With the pharmacy functions, it is very much huge and complex.

I tried to understand these complex and huge characteristics, nature, functions etc. However, I tried my best to blend with these situations and realized most of these things. In a short time, it is impossible to learn all things.

In the duration of nine weeks, I also tried to gather all the information and knowledge from different text books, brochures to understand the difficult task of IBN SINA. In this report, I have presented those in proper, chronological and precise way.

At the end, I can only state that by this Internship Program I am able to complete my BBA course from Uttara University. I found all sorts of co-operation and good work environment in two months working with IBN SINA. Everybody concerned with management and administration of IBN SINA was compassionate to me.

4|Page

Internship Report on

"Service Performance of IBN SINA"

Acknowledgement
A lot of concentration, effort, responsibility and study have been involved in preparing this paper into reality. In preparing a report one needs a number assistance and guidance from reliable sources. This report also stands on the basis of such efforts. I have pleasure to express my gratitude to the internship and placement committee for arranging such a program from which I have carried a lot of practical experience.

At the very outset, I would like to express my profound respect to my honorable teacher Nighat Farzana, lecturer of business faculty, who is my supervisor, of Internship Program designed for the BBA students. Her continuous supervision has inspired me to make a more feasible report based on in-depth analysis.

In preparing the report, I received active co-operations from the AVP, Second Officer, Officers of IBN SINA. I sincerely express my heart-felt gratitude to them for their Cooperation, which helped me to conduct and complete this Report. Those theyre frankly, dynamic and helped me seriously and given me their valuable time during my internship program. Some time I did interfere in their most important work by asking many questions for my internship purpose and theyre very polite and willing to my questions with patience.

However, to my best I tried very hard and worked sincerely to prepare this report an informative one. At last, my sincere apology goes to the readers for my conceptual & printing mistake, if there is any.

5|Page

Internship Report on

"Service Performance of IBN SINA"

Executive Summary
Bangladesh has a vibrant pharmaceutical industry. The country is almost self-sufficient in this sector with 97% of the countrys needs being met by the local manufacturers. Currently valued at BDT 84 billion (USD 1 billion), the pharmaceutical market has been growing steadily over the last few years. This industry has been consistently performing theyll with a CAGR of 20% in the last 3 years. From the positive trends in this sector, including increased healthcare spending on medicine and medical coverage, enhanced healthcare system, and rising government expenditure, IBN SINA expect the industry to continue to register healthy growths in the foreseeable future. The sector is highly fragmented with 246 manufacturers: top 10 companies enjoy more than 67% while top 20 companies have 85% of the market share. All of the top 10 players are local manufacturers. IBN SINA predict that domestic players will continue to dominate and become more competitive with further backward integration in the near future and at the same time go up the value chain with increasing focus on technology driven products. The report is based on two months (14th October to 10th December 2012) working experience on IBN SINA. I was assigned in the Dhanmondi branch. This report gives a clear idea of the activities, operation strategies and the performance of IBN SINA, incorporated in 2001 and become operational with view to provide exclusive service facilities to its client and accordingly meet the demand of pharmaceuticals service all over Bangladesh.

The working environment of IBN SINA is very conductive and friendly. The staffs are specialized in their respective fields. Each of them works on their own and there is close supervision from the top. The motivation of the employees, I believe comes from the very sense of responsibility. Each member is individually responsible for his or her work. My overall experience had been very fascinating and I believe internship period of IBN SINA will definitely help me a lot in building me future career.

6|Page

Internship Report on

"Service Performance of IBN SINA"

Table of Content
Chapter No.
Letter of Transmittal. Preface. Acknowledgement. Executive Summary.

Title

Page No.
03 04 05 06

Chapter 01

1.1 Background of the Study 1.2 Methodology. a) Primary source of data. b) Secondary source of data. 1.3 Objective of the Study. 1.4 Scope of the Study. 1.5 Limitation of the Study.

11 12 12 12 13 14 15

Chapter 02

Introduction. 2.1 History of IBN SINA pharmaceuticals Ltd 2.2 Vision. 2.3 Mission. 2.4 IBN SINA dare to Dream

17 17-18 18 18 19

7|Page

Internship Report on

"Service Performance of IBN SINA" Chapter 03 Marketing Strategies of IBN SINA 20

Chapter 04

4.1 Manufacturing Capability of IBN SINA a) Oral Solid Dosage. b) Metered Dose Inhaler. c) Intravenous Fluid. d) Pre- Filled Syringe.

22 23 25 26 26

Chapter 05

5.1 Health Solution of IBN SINA 5.2 Knowledge based Performance service. 5.3 Response to the Community at Large. a) Trusted partner in Health. b) Awareness Campaign. c) Employee Volunteering Program. d) Preserving Cultural Heritage. 5.4 Responsibility to the environment. 5.5 Responsibility to the Stakeholders.

28 29 29 30 30 30 30 31 31

Chapter 06

SWOT analysis of Jamuna Bank Ltd.

32

Chapter 07

Findings & Analysis. Recommendation. Conclusion. References

33 34 35 36

8|Page

Internship Report on

"Service Performance of IBN SINA"

Orientation of the Report

9|Page

Internship Report on

"Service Performance of IBN SINA"

1.1 Background of the Study


Pharmaceuticals sector are the key financial institutions that play a vital role in the countrys economy. Globalization in the pharmaceuticals sector has thrown up opportunities as theyll as challenges. Competition is getting edge day by day. It paces with the continuous development occurring in the tremendous competitive environment.

To keep pace with this situation, they need pharmaceuticals knowledge for future career. If they want to build our career in this area, only theoretical knowledge would not help us. As internship program is established to gather practical knowledge regarding various sector of economy, I chose to get practical knowledge regarding this sector and I select IBN SINA pharmaceuticals Ltd, as my organization to work.

The duration of my program was nine weeks and during this period, I have learned many things. I observed that there is a great difference between theoretical knowledge and practical knowledge. I learned many terms, functions and nature of pharmaceuticals activities. I also get practical knowledge regarding organizational environment.

10 | P a g e

Internship Report on

"Service Performance of IBN SINA"

1.2 Methodology
A sample survey was conducted to collect primary data using two pre-designed survey instruments from concerned groups following an appropriate sample design. In view of the complexities involved in generating quantitative data for assessing the real impact, qualitative data theyre also collected using Focus Group Discussions (FGDs). In the context of the unique features of the area an attempt was made to identify the strengths, their weaknesses, opportunities and threats of the pharmaceuticals sector. Data Collection This study is mainly based on secondary data available from the various divisions and departments of IBN SINA pharmaceuticals Ltd, in addition to these other necessary information have been collected from the daily newspapers, relevant journals, annual reports of IBN SINA, They side and publications of other relevant institutions have also been taken into consideration. Primary sources of data: Face to face conversation with the pharmacy officers & staffs. Conversation with the clients. Different' manuals of IBN SINA. Different circulars of IBN SINA. Discussion with pharmacy Officers. Personal observation. Desk work in different sections/departments.

Secondary sources of data: Procedure manual published by the IBN SINA. Files and documents of the pharmacy. Annual report of IBN SINA, 2010-2011 Different papers of IBN SINA. Unpublished data.

11 | P a g e

Internship Report on

"Service Performance of IBN SINA"

1.3 Objective of the Study


The main objective of this study is to have some practical exposures that will be helpful for my Final year courses in the BBA Program.

To achieve the broad objective the following specific objectives has been attained: To find out the marketing strategy of IBN SINA Pharmaceuticals Ltd. To find the financial performance of IBN SINA Pharmaceuticals Ltd. Analyzing the performance of the pharmacy. To find out the different procedures of the pharmacy. To know the competitive strength and weakness of the pharmacy. To know the marketing and expansion strategy of pharmacy that can help to face the potential threats and opportunities. To know the technological advantage and lacking of this pharmacy in the modern pharmaceutical system. To find out the relations among the various department. To make a bridge between the theories & practical procedures of pharmacy day-today operations. To make possible recommendations for the internship organization to improve the services & service range so that the department can cater to the needs and demands of customers.

12 | P a g e

Internship Report on

"Service Performance of IBN SINA"

1.4 Scope of the Study


At IBN SINA Pharmaceuticals Ltd, I have firstly tried to acquire knowledge and experience about the overall pharmacy system. The report mainly focused on Service performance of IBN SINA.

Here I have discussed about overall services and functions rendered by IBN SINA Pharmaceuticals Ltd, i.e. customer advance, clearing, cash department, foreign exchange department & modern equipment used by the pharmacy, which have been observed during the two months Internship program.

The report also finds out some possible recommendations, which might be taken or accepted by the management of the pharmacy.

13 | P a g e

Internship Report on

"Service Performance of IBN SINA"

1.5 Limitations of the Study


Despite my sincerest endeavor in preparing a perfect report, some of the limitations are inescapable. These are as follows:

Within such a short period of time (nine weeks), it was not possible for me to study everything about IBN SINA Pharmaceuticals Ltd. The officers are so much busy that they cannot properly co-operate with me, which are a problem. Pharmacys policy of not disclosing some data and information for obvious reason, which could be very much useful. To analysis SWOT of emerging market is a wide spread survey material. However, time constraint restricted the report to specific feature. The study requires experience to be fruitful but it was completely absent to me. Sometimes the officials theyre reluctant to give proper information regarding their activities because they felt hesitation and ambiguity to give data and information.

Lack of personal knowledge and experience.

14 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Introduction

15 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Introduction 2.1 History of IBN SINA Pharmaceuticals Ltd


IBN SINA Pharmaceuticals Ltd. belongs to IBN SINA Group, the largest private sector business conglomerate in Bangladesh. Incorporated in the late 70s, IBN SINA Pharma began as a distributor, importing products from global MNCs like Bayer, Germany and Upjohn Inc., USA and selling them in the local market, which theyre later manufactured and distributed under licensing arrangements.

The Company introduced its own branded generic products in 1983. Since then, the journey continued, and today, IBN SINA Pharma is a leading manufacturer and exporter of pharmaceuticals in the country, winning National Export Trophy (Gold) a record four times. IBN SINA Pharmas manufacturing facilities have been accredited by major global regulatory bodies, and it has expanded its geographic footprint across four continents.

IBN SINA Pharma is the only Bangladeshi company listed on the AIM of London Stock Exchange through issuance of GDRs.

Having a broad portfolio of more than 500 products and a dedicated team of around 2,700 employees, IBN SINA Pharma is committed to providing access to medicines which are affordable and manufactured in strict compliance with global standards.

2.2 Vision
They will be one of the most trusted, admired and successful pharmaceutical companies in the region with a focus on strengthening research and development capabilities, creating partnerships and building presence across the globe.

16 | P a g e

Internship Report on

"Service Performance of IBN SINA"

2.3 Mission
They are committed to enhancing human health and theyll being by providing contemporary and affordable medicines, manufactured in full compliance with global quality standards. They continually strive to improve our core capabilities to address the unmet medical needs of patients and to deliver outstanding results for our shareholders.

17 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Marketing Strategy of IBN SINA

18 | P a g e

Internship Report on

"Service Performance of IBN SINA"

3.1 Marketing Strategies of IBN SINA Pharmaceuticals Limited


To attain the above vision and mission IBN SINA follow the following Marketing Strategies:
Providing efficient customer service. Maintaining corporate and business ethics. Being trusted repository of customers and their financial advices. Making its products superior and rewarding to the customers. Display team spirit and professionalism. Sound capital base. Enhancement of shareholders wealth. Fulfilling its social commitments by expanding its charitable and humanitarian activities. Providing high quality financial services in export and import trade. Building tight personal relationship with customers and clients. Taking less promotional activities and emphasizing on relationship marketing.

19 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Manufacturing Capability

20 | P a g e

Internship Report on

"Service Performance of IBN SINA"

4.1 Manufacturing Capability of IBN SINA


Situated at Tongi, near the capital city Dhaka, IBN SINAs manufacturing site extends over an area of 23 acres. The site houses manufacturing facilities for producing various drug formulae in different strengths and delivery systems such as capsules, tablets, intravenous fluids, metered dose inhalers, sterile ophthalmic drops, prefilled syringes, dry powder inhalers, injectable, nebulizer solutions, creams, ointments, suppositories, etc. The site has its own utility infrastructure to ensure adequate generation and distribution of electricity with an installed capacity of 10MW, in addition to water purifying and liquid nitrogen generation facilities. The bulk drug unit for producing paracetamol is also located within this site. The Companys penicillin API and formulation units are situated at Kaliakoir, 20 km from the main site.

4.1.1 Oral Solid Dosage


The state-of-the-art Oral Solid Dosage unit is designed as per US FDA standards. The facility incorporates contemporary technological advancements with automated material handling systems and multilevel designs to enable gravity feed between various processing stages. This facility houses a total of five lines with an annual capacity to produce 5 billion tablets. This facility is already accredited by the regulatory authorities of EU, Australia and the Gulf member states, and is awaiting inspection and approvals from the USFDA, which would give IBN SINA Pharma access to the most regulated markets in the world.

4.1.2 Metered Dose Inhaler


IBN SINA Pharma was among the first few companies in the world who made the transition away from CFC-based inhalers to the ozone-benign HFA based formulations, in compliance with the Montreal Protocol. As CFCs are harmful to the earths protective ozone layer, the Company proactively developed ozone-benign HFA based MDIs which inevitably require very high level of expertise and sophisticated technology. The company is currently the 21 | P a g e

Internship Report on

"Service Performance of IBN SINA"

largest producer of MDIs in Bangladesh, and it produces a popular inhaler brand for a reputed MNC under a contract manufacturing agreement.

4.1.3 Intravenous Fluid


The Intravenous (IV) fluid unit is ISO 9001: 2010 certified and was designed in collaboration with Pharma Plan, a sister concern of Fresenius AG of Germany. Absolute sterile manufacturing conditions are rigorously maintained through a series of fully automated manufacturing procedures including robotics. The facility utilizes FFS (Form-Fill-Seal) Bottelpack aseptic system of Pharma Plan Germany. Plastic bottles are blow molded, filled with the solution and sealed under sterile conditions, in a single working cycle where there is no environmental exposure or human contact during manufacturing. The whole process is performed in a class 100 environment which ensures the highest standards of quality and purity. The facility produces a broad assortment of large volume parenteral (LVPs). As a line extension of this IV unit, the company has installed an amino acid line to produce a range of parenteral nutrition products such as Nutrimin and Nutrimin D.

4.1.4 Pre-Filled Syringe


Prefilled syringes (PFS) provide both convenience and accuracy to self-administered drugs. With their ease of use and improved safety features PFS has become one of most widely used drug delivery systems today. IBN SINA Pharma launched its PFS range with Enoxaparin Sodium, a low molecular height heparin, which is widely used in cardiac emergency. The Company plans to add a few more high value products to its PFS portfolio shortly. The high precision PFS line employs sophisticated technology and the entire filling operation is done under laminar flow in a class 100 environment to provide absolute sterile conditions.

22 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Service Performance of IBN SINA

23 | P a g e

Internship Report on

"Service Performance of IBN SINA"

5.1 IBN SINA Health Solutions


IBN SINA offer their customers a comprehensive and high-quality product portfolio encompassing all major therapeutic categories, available in various dosage forms including tablets, capsules, syrup, suspension, sterile eye drops, injectable, nasal sprays, creams, ointments, suppositories, IV fluids, metered dose inhalers, dry powder inhalers, prefilled syringes etc.

Their therapeutic groups host quality solutions for treating cardiovascular, musculoskeletal, endocrine, gastrointestinal, metabolic, allergic, respiratory and other disorders. Currently, IBN SINA Pharma produces 284 generics in 508 strengths and dosage forms. Time after time, their pharmaceutical brands are found in the top ranks in their respective therapeutic categories.

In the domestic market, IBN SINA Pharma maintained its leadership position in key therapeutic segments such as gastrointestinal and analgesic.

2011 was a year of restructuring spirits for their Marketing and Sales teams. The sales division was restructured to pay particular attention to specialty and chronic care products, with the goal of registering considerable growth in these categories in the near future. To add to the momentum, the teams theyre also more aggressive than before in the race to the top. In the year under review, the Company experienced a significantly more extended doctor reach as theyll as enhanced distribution reach. This is very important for them because, todays efforts at brand building will help them create a stronger platform for tomorrows blockbuster products to carry on with high performance in keeping with the likes of their emerging brands such as Amdocal Plus, Atova, Azmasol etc.

In the domestic market, their product brand equity remained respectably strong. When it comes to the generic pharmaceutical markets, it is rightly said that prescription generation is key to a pharmaceutical companys health. 24 | P a g e

Internship Report on

"Service Performance of IBN SINA"

On a bright note, IBN SINA Pharmas prescription (Rx) share in terms of both product and value crossed the double digits Rx share benchmark during the year.

To keep the impetus flowing, the Company shall continue to strengthen market penetration beyond urban areas through their wholly-owned distribution network and further augment their value added services for doctors.

5.2 Knowledge-based professional services


In 2011, they served the medical community with complementary knowledge-based professional services such as the following: Conducted around 300 clinical meetings nationwide. Responded to over 1100 doctors by providing assistance according to their requests. Responded to approximately 1000 doctors by sending latest clinical and medical journals on a regular basis as per interest. Prepared over 50 slide presentations on behalf of doctors on various occasions. Prepared several poster presentations on behalf of doctors for both national and international occasions. Published 4 quarterly Medical Newsletter. Published 12 online monthly E-Newsletter on Ophthalmology. Published Cardiovascular Therapeutic Index.

25 | P a g e

Internship Report on

"Service Performance of IBN SINA"

5.3 Responsibility to the Community at Large


Our vision is to make significant contribution to humanity by improving health. This vision guides our Companys operations, including its commitment to corporate responsibility.

Trusted Partner in Health They work together with non-profit organizations who work to improve people's lives through research, information, and advocacy. As the Company writes its success story as an emerging leader in the pharmaceutical industry, they also realize that responsibility towards all our stakeholders increases in tandem. They remain committed to being a good corporate citizen. In the year under review, they joined Mobile Alliance for Maternal Action (MAMA) in Bangladesh. MAMA is a country-owned, country-led initiative managed by an alliance of stakeholders. Through a core group of founding partners, MAMA Bangladesh is designing and testing a platform to provide both audio and text health messages to pregnant women and new mothers linked to their delivery date. The service also includes family gatekeepers for inspiring healthcare seeking behavior. The commercial brand name to be tested is Aponjon. As part of the new United States Global Health Initiative, the United States Agency for International Development (USAID) catalyzed the creation of a public-private coalition in Bangladesh to support the execution of the service. The Ministry of Health and Family They fare (MOHFW) and Access to Information (A2I) Program at Prime Minister's Office are official partners of the initiative. Global partners include Johnson & Johnson and United Nations Foundation, among others.

The Objectives of the initiative are as follows: Reach 500,000 pregnant women and new mothers within three years. Deliver critical life-saving health messages, leading to sustained improvements in health knowledge, behaviors and outcomes. Build upon USAID and Government of Bangladesh maternal child health and family planning programs. 26 | P a g e

Internship Report on

"Service Performance of IBN SINA"

MAMA coalition activities are being organized by D.Net, a leading social enterprise working for integration of ICTs in education, health, livelihood and social accountability.

Awareness Campaigns Prevention is the best cure and the first step is to create awareness. Every year, they launch campaigns touching on different forms of heath impediments ranging from asthma, diabetes, hypertension and many more. Campaign activities include rallies in addition to organizing and sponsoring scientific seminars and conferences for various associations and societies in medical disciplines.

Employee Volunteering Program In this program, IBN SINA sent employee volunteers to devote their time and energy in spreading smiles across the faces of children battling the ultimate battle of survival against cancer. The children are currently being treated at the ASHIC Foundation. They arranged an outing at an amusement park in the capital city where the children theyre accompanied by their parents and representatives from the not-for-profit organization. They had a wonderful day together packed with fun rides and great food. Later on they donated hospital equipment to the palliative care unit where the children at the terminal stage of cancer are being treated. The ASHIC foundation is a full member of International Confederation of Childhood Cancer Parents Organization (ICCCPO), which is an international forum to increase awareness and action on childhood cancer related issues.

This small Foundation strives to improve the quality of life for children living with cancer in Bangladesh by providing hope, physical and emotional support, and raising public awareness for early detection, improved treatment and social acceptance. They appreciate their noble cause and extended IBN SINAs support.

They believe that a genuine spirit of giving itself is credential enough and therefore they stand by the unsung heroes who dedicate their lives for the betterment but do not get the 27 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Recognition or enough support to carry out their intentions with optimized efficiency and impact.

Preserving Cultural Heritage Preservation and promotion of cultural heritage are linked to economic they fare of any country. They at IBN SINA vibrant heritage in a way that would imprint its immortal beauty in the hearts of their todays modern demography and the generations to come. In 2011, they sponsored and organized the grand cultural event, at the National Museum, marking the 150th birth anniversary of Rabindranath Tagore; the legend who had irrefutable contribution towards the heritage and identity distribution of a comprehensive documentary, highlighting Rabindranath Tagore's intermittent stay in Bangladesh. It was premiered on 7th May at the National Museum, Dhaka. The documentary, based on research by the eminent Tagore researcher Ahmed Rafique, was directed by Dr. Chanchal Khan, better known as a Tagore singer distinguished personalities and recitals. The rich content lends it historical, archival and educational value.

Pharma hope to preserve and promote our countries of Bengali culture. They also sponsored the making and exponent. Elements of the documentary include nine songs that theyre penned by the Nobel laureate poet during his stay in Bangladesh. Childrens Education is a Right, not a Privilege IBN SINA Pharma, being in knowledge based industry, fully understands the crucial role that education plays in the building of a nation. They offer financial assistance to the children, of their employees, who are brilliant and possess a thirst for knowledge; and yet may not be able to actualize their dreams due to unfavorable financial circumstances. In the year 2011, IBN SINA Pharma offered assistance to a total of 36 meritorious students coming from diverse academic backgrounds.

28 | P a g e

Internship Report on

"Service Performance of IBN SINA"

5.4 Responsibility to the Environment


They are always aware of environmental compliance and adopt policy to preserve the environment by practically minimizing emission and waste, thereby reducing our carbon footprint. The premise that drives us is they always put the needs of people before anything else in every chapter of our success story. Our Safety, Health and Environment (SHE) program is also based on a framework of consistent standards.

Our Path to Protecting the Ozone Layer Inhaled therapy is essential for the treatment of patients with asthma and COPD. Unfortunately, CFC gases used in inhalers as propellants have ozone-depleting properties. The Montreal Protocol on Substances that Deplete the Ozone Layer, the international agreement that established measures to control ozone-depleting substances, made it mandatory for Bangladesh and many other countries to implement and complete the phaseout of CFC based MDIs by December 31, 2009. It was a challenge for Bangladesh to make the transition from ozone-depleting CFC to ozone-benign HFA-based inhalers to save the environment and to ensure availability of inhalers for the patients. In 2006, theyre the first Bangladeshi company to proactively and successfully make the shift to HFA inhalers to ensure that no patient in Bangladesh suffers from a lack of availability of MDIs when CFC would become scarce in the future. This was an enormous feat not only for a developing country like Bangladesh but also for the world at large. In addition to proactively adopting ozone-benign HFAs, IBN SINA Pharma actively advocated so that others would also do the same. As a follow-up to UNEPs Langkawi Declaration on Public-Private Partnership, IBN SINA Pharmaceuticals Ltd. and Bangladesh Lung Foundation, designed an effective awareness raising strategy for CFC-free MDIs for asthma and COPD patients. Today, they are the single largest producer of ozone-benign MDI in Bangladesh, and as a responsible company they conduct theyll thought-out multi-stakeholder campaigns when they launch a product. Such partnerships are now regarded as a successful role model of public-private 29 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Partnership involving government, pharmaceutical industries, doctors, environmental agencies and others stakeholders that could be replicated in other developing countries.

5.5 Responsibility to the Stakeholders


Even though at the core of any business is the aim to maximize profit, they actively look out for their stakeholders best interest and ensure that their growth is sustainable in the long run. Once again, this year they achieved substantial growth and surpassed the industry average. From the handsome revenues earned, they always make it a point to invest in the future. They are committed to ensure the optimal utilization of resources in order to create and sustainably maintain their shareholders health. Every day they are mindful of their responsibilities to create value for their community, for instance, their support for Save the Childrens program on human rights; nourishing employee relations through the creation and maintenance of employment; creating change though environmental stewardship and progressing into the future with excellence in financial performance. In their everyday interactions with their stakeholders including employees, customers, suppliers, competitors and so on, they do their utmost to maintain integrity and fairness in all dealings.

30 | P a g e

Internship Report on

"Service Performance of IBN SINA"

SWOT Analysis

31 | P a g e

Internship Report on

"Service Performance of IBN SINA"

SWOT ANALYSIS
SWOT analysis means the analysis of strength, weakness, opportunity and threats. For IBN SINA Ltd. It is given below:

Strength
IBN SINA Ltd is a rapidly expending Company. Standing its journey in 1998 it has already doubled the net turnover by the year of 2006. All the units of the pharmacy enjoy highly of machinery are imported from Germany, Switzerland, Italy & Japan. As a result it can maintain a smooth rate of production. Well trained human recourses are strength of the Company. They train up their key personally in the country and abroad. So that the Company can get some competitive advantages over the competitions. The HRM practice is also remarkable.

Weakness
There are too many departments under the super vision of the general manager which can cause low productivity due to large span of super vision.

Opportunity
There are bright opportunities for the Company in the overseas market. If it can communicate well and capture a significant market portion in the Europe and USA market, it can get scale of economic.

32 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Threats
BPL has a commitment to the society to supply world class Active Pharmaceutical Ingredients (APIs). Therefore, BPL is not only engaged in formulations but also in fi ne chemicals business with a view to supplying cost effective quality y materials to other local companies as well as for captive consumption. IBN SINA Pharmaceuticals Ltd has been preparing itself for the post-WTO open market competition. It has all the courage to compete with world leaders in pharmaceuticals business when the tariff and non-tariff barriers will be withdrawn the new USFDA standard plant is planned to be operational in early 2003. Once completed, this will be one of the finest facilities to be available anywhere in the globe.

33 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Findings, Recommendation & Conclusion

34 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Findings
IBN SINA adopts industry best practices in all their operations to ensure highest quality standards of their products. They are committed to satisfying the needs of their customers, both internal and external. They give high priority on building capabilities of their employees and empower them to realize their full potential. They encourage transparency in everything they do and strictly adhere to the highest ethical standards. They are accountable for their own actions and responsible for sustaining corporate reputation. They actively take part in initiatives that benefit their society and contribute to the welfare of their people. They take great care in managing their operations with high concern for safety and environment.

Recommendations
From the analysis with the organization structure we have seen that its span of super vision is too large. A number of departments report directly to the general manager. If the number were less the efficiency and productivity of the organization might be increased. Quality control department should remain prompt always. So that it can maintain a certain level of standard as per the market demand to capture the foreign market share it should strive more.

35 | P a g e

Internship Report on

"Service Performance of IBN SINA"

Conclusion
The flourishment of any industry requires combined efforts and cooperation from several parties. Social, political and macro-economic environment play pivotal role in this regard. Though IBN SINA pharmaceuticals Ltd is a newly Ventured Company in the respective sector, its growth and expansion is praiseworthy. Its contributing the country and serving the nation in different ways. If it can up hold its much toward advancement, it will be able to set a role model in our country.

36 | P a g e

Internship Report on

"Service Performance of IBN SINA"

References
Books L.Franch.Wendell and H.Bell.Cecil 2001.Consumer Behavior 6th Edition. Annual Report
Annual report 2009 IBN SINA pharmaceuticals Ltd. Annual report 2010 IBN SINA pharmaceuticals Ltd. Annual report 2011 IBN SINA pharmaceuticals Ltd.

Hand note
Mr. Md. Belal Hossain (manage) and Mr.Biplom Kumar Chakraborty (FAVP) (General Manager)

Website
IBN SINA. Available from http://www.ibnsinabd.com/info IBN SINA Limited 2012, History of IBN SINA, available from

http://www.ibnsinabd.com http://www.Swift.co

37 | P a g e